Evidence map›Paper›PMID 34217291›Full record

ArticleMicrobial cell factories2021

Analysis and application of a suite of recombinant endo-β(1,3)-D-glucanases for studying fungal cell walls.

Vanessa S D Carvalho, Laura Gómez-Delgado, M Ángeles Curto, M Belén Moreno, Pilar Pérez, Juan Carlos Ribas, Juan Carlos G Cortés

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 20 citations in OpenAlex.

  1. Development of a RobustMicroorganisms · 2024
    Article
  2. Analysis of the Localization ofInternational journal of molecular sciences · 2023
    Article
  3. Analysis of Biochemical and Genetic Variability ofJournal of fungi (Basel, Switzerland) · 2022
    Article
  4. Special Issue 'Microbial glycobiotechnology'.Microbial cell factories · 2022
    Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Vanessa S D CarvalhoInstituto de Biología Funcional y Genómica Zacarías González, 2. CSIC and Universidad de Salamanca, 37007, Salamanca, Spain.
Laura Gómez-DelgadoInstituto de Biología Funcional y Genómica Zacarías González, 2. CSIC and Universidad de Salamanca, 37007, Salamanca, Spain.
M Ángeles CurtoInstituto de Biología Funcional y Genómica Zacarías González, 2. CSIC and Universidad de Salamanca, 37007, Salamanca, Spain.
M Belén MorenoInstituto de Biología Funcional y Genómica Zacarías González, 2. CSIC and Universidad de Salamanca, 37007, Salamanca, Spain.
Pilar PérezInstituto de Biología Funcional y Genómica Zacarías González, 2. CSIC and Universidad de Salamanca, 37007, Salamanca, Spain.ORCID http://orcid.org/0000-0003-3557-2247
Juan Carlos RibasInstituto de Biología Funcional y Genómica Zacarías González, 2. CSIC and Universidad de Salamanca, 37007, Salamanca, Spain. ribas@usal.es.ORCID http://orcid.org/0000-0001-6430-0895
Juan Carlos G CortésInstituto de Biología Funcional y Genómica Zacarías González, 2. CSIC and Universidad de Salamanca, 37007, Salamanca, Spain. cortes@usal.es.ORCID http://orcid.org/0000-0002-2395-6668
Universidad de Salamanca · ES

Funding

Consejería de Educación, Junta de Castilla y León CLU-2017-03Consejería de Educación, Junta de Castilla y León CSI150P20Ministerio de Ciencia, Innovación y Universidades PGC2018-098924-B-I00
6 · The paper itself

Abstract

backgroundThe fungal cell wall is an essential and robust external structure that protects the cell from the environment. It is mainly composed of polysaccharides with different functions, some of which are necessary for cell integrity. Thus, the process of fractionation and analysis of cell wall polysaccharides is useful for studying the function and relevance of each polysaccharide, as well as for developing a variety of practical and commercial applications. This method can be used to study the mechanisms that regulate cell morphogenesis and integrity, giving rise to information that could be applied in the design of new antifungal drugs. Nonetheless, for this method to be reliable, the availability of trustworthy commercial recombinant cell wall degrading enzymes with non-contaminating activities is vital.

resultsHere we examined the efficiency and reproducibility of 12 recombinant endo-β(1,3)-D-glucanases for specifically degrading the cell wall β(1,3)-D-glucan by using a fast and reliable protocol of fractionation and analysis of the fission yeast cell wall. This protocol combines enzymatic and chemical degradation to fractionate the cell wall into the four main polymers: galactomannoproteins, α-glucan, β(1,3)-D-glucan and β(1,6)-D-glucan. We found that the GH16 endo-β(1,3)-D-glucanase PfLam16A from Pyrococcus furiosus was able to completely and reproducibly degrade β(1,3)-D-glucan without causing the release of other polymers. The cell wall degradation caused by PfLam16A was similar to that of Quantazyme, a recombinant endo-β(1,3)-D-glucanase no longer commercially available. Moreover, other recombinant β(1,3)-D-glucanases caused either incomplete or excessive degradation, suggesting deficient access to the substrate or release of other polysaccharides.

conclusionsThe discovery of a reliable and efficient recombinant endo-β(1,3)-D-glucanase, capable of replacing the previously mentioned enzyme, will be useful for carrying out studies requiring the digestion of the fungal cell wall β(1,3)-D-glucan. This new commercial endo-β(1,3)-D-glucanase will allow the study of the cell wall composition under different conditions, along the cell cycle, in response to environmental changes or in cell wall mutants. Furthermore, this enzyme will also be greatly valuable for other practical and commercial applications such as genome research, chromosomes extraction, cell transformation, protoplast formation, cell fusion, cell disruption, industrial processes and studies of new antifungals that specifically target cell wall synthesis.

Indexed as

beta-GlucansCell WallGlucan Endo-1,3-beta-D-GlucosidaseRecombinant ProteinsSchizosaccharomycesbeta-1,3-glucanbeta-GlucansGlucan Endo-1,3-beta-D-GlucosidaseRecombinant ProteinsCell wallFission yeastFungiRecombinant endo-β(1,3)-D-glucanaseβ(1,3)-D-glucan

Identifiers

PMID34217291
PMCPMC8254974
OpenAlexW3182382254

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.